1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsEngineering Biology Collaborative R&D: Round 3 is sponsored by Innovate UK (part of UKRI's Engineering Biology Programme). This program supports UK registered businesses in developing and scaling Engineering Biology platforms, products, and services.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Engineering Biology Collaborative R&D: Round 3 - Innovate UK Business Connect Knowledge Transfer Partnerships Engineering Biology Collaborative R&D: Round 3 Engineering Biology Collaborative R&D: Round 3 UK registered businesses can apply for a share of up to £8. 5 million to develop and scale Engineering Biology platforms, products and services. This funding is part of UKRI’s Engineering Biology Programme.
[term_taxonomy_id] => 397 [taxonomy] => type_of_funding [taxonomy] => type_of_funding East Midlands , East of England , London and the South East , North East (England) , North West (England) , Northern Ireland , Scotland , South West (England) , Wales , West Midlands , Yorkshire and The Humber Your project’s total eligible costs must be between £750,000 and £2. 5 million. Up to 70% of costs can be covered, depending on business size.
Agrifood , Biotechnology , Chemistry , Health , Materials , Sustainability , Transport Innovate UK, part of UK Research and Innovation (UKRI), will invest up to £8. 5 million from the UKRI’s Engineering Biology Programme . The funding total is subject to a sufficient number of high quality applications being received.
The aim of this competition is to deliver business led research and development that will: lead to new engineering biology products, processes or services de-risk the adoption of new engineering biology technologies that offer high market potential Your project must focus on developing or applying engineering biology solutions to one or more of the following themes: Cross cutting technology, service development Projects must be collaborative, business-led, and involve at least one UK SME.
You must address supply chain validation through involvement of at least one named end user in the project, for example, an OEM, Tier 1, or other organisation further downstream in the supply chain. We are particularly interested in projects that address well defined engineering biology scale up constraints and market led capability gaps, and which can demonstrate how the proposed innovation will create growth and value in the UK.
This competition has a two stage assessment process. If your application passes the first stage of assessment, you may be invited to attend an interview , where you must give a presentation. Our experience from similar competitions suggests that you could have up to a 20% chance of success.
If your project is not yet ready to involve an end user but is looking to scale up or validate at scale, you may be eligible for the Engineering Biology Access to Infrastructure Pilot competition, which is open until 21 October 2026, with eligible costs of £250k-£700k for scale up and validation projects. const el = $refs['accordion1']; const top = el. getBoundingClientRect().
top + window. pageYOffset - 80; // adjust offset window. scrollTo({ top, behavior: 'smooth' }); To lead a collaborative project your organisation must be a UK registered business of any size.
The consortium must contain at least one UK registered micro, small or medium sized enterprise (SME) claiming grant funding on this application. To collaborate with the lead, your organisation must be one of the following UK registered: public sector organisation research and technology organisation (RTO) No single organisation can claim more than 70% of the total project costs. An eligible organisation can only lead on one application.
An eligible organisation that is leading an application can be included as a collaborator in a further two applications and if not leading, can collaborate in any number of applications. const el = $refs['accordion2']; const top = el. getBoundingClientRect().
top + window. pageYOffset - 80; // adjust offset window. scrollTo({ top, behavior: 'smooth' }); have total costs of between £750,000 and £2.
5 million (up to 70% of costs can be covered, depending on business size) last between 12 and 36 months not start before 1 April 2027 No single organisation can claim more than 70% of the total project costs. Any organisation receiving funding must carry out its project work in the UK, intend to exploit the results in the UK, and spend most of the funding within the UK. const el = $refs['accordion3']; const top = el.
getBoundingClientRect(). top + window. pageYOffset - 80; // adjust offset window.
scrollTo({ top, behavior: 'smooth' }); The aim of this competition is to deliver business led research and development that will: lead to new engineering biology products, processes or services de-risk the adoption of engineering biology technologies that offer high market potential The funding support will help to accelerate the development and adoption of engineering biology technologies and techniques, driving economic growth from UK strengths in research and innovation and by doing so provide solutions to societal challenges.
To be considered within scope for this competition, the primary innovation and competitive advantage underpinning the project must arise from or enable engineering biology. For the purposes of this competitions engineering biology is defined as the purposeful engineering of biological systems. These will create new or enhanced functions that do not occur naturally, or that cannot be achieved efficiently through conventional approaches.
This includes the design, modification or creation of organisms, cells, genetic circuits, enzymes, proteins or other biomolecular systems that exhibit novel or enhanced functionality.
Your solution can focus on one or more of the following technologies in which the core innovation is in engineered biological systems, for example, built on synthetic biology techniques: Biosensors and Diagnostics Biocatalysis and Chemical Production Engineered Proteins and Enzymes Cell and Microbe Engineering Synthetic Biology Platforms Gene Editing and Genome Engineering AI and Computational Biology demonstrate how you will address a real commercialisation constraint in the UK and focus on applying engineering biology solutions to one or more cross cutting engineering biology technologies, products or services apply engineering biology solutions to one or more of the UKRI’s Engineering Biology Priority Programme themes be collaborative industrial research focus on solutions that are either new or not yet widely used demonstrate how your innovation relates to engineering biology explain how your innovation fits with one or more of the specific themes for the competition address supply chain validation through involvement of at least one named end user in the project, for example, an OEM, Tier 1, or other organisation further downstream in the supply chain Elements of the project work that support the translation, validation, scale-up, manufacturing, regulatory progression, product development or commercial deployment will be supported through this competition.
This is providing that they are directly enabled by, and derive value from, the underlying engineering biology innovation. const el = $refs['accordion4']; const top = el. getBoundingClientRect().
top + window. pageYOffset - 80; // adjust offset window. scrollTo({ top, behavior: 'smooth' }); Your project must address supply chain validation through involvement of at least one named end user in the project, for example, an OEM, Tier 1, or other organisation further downstream in the supply chain.
The involvement of the end user can be in the form of, but is not limited to: being on a project advisory board being a non-funded or funded project collaborator The named end user is the organisation, further along the supply chain, that will use or directly benefit from the innovation. The end user must have a clear, defined role within the project governance or work plan.
Government organisations, regulators or academic institutions can only be end users where you provide a clear justification, for example, where they act as a system integrator or service provider for the innovation. In this competition we will not accept consultancies as end users. const el = $refs['accordion5']; const top = el.
getBoundingClientRect(). top + window. pageYOffset - 80; // adjust offset window.
scrollTo({ top, behavior: 'smooth' }); Specific themes and exclusions Your project must focus on developing or applying engineering biology solutions to one or more of the following themes: Cross cutting technology, service development We are not funding projects that: are not engineering biology focused are not focussed on the competition themes include the clinical development of any biologic, vaccine or engineering biology derived small molecule are for clinical trials or preclinical evaluation of therapeutics are fundamental research, feasibility studies or discovery based const el = $refs['accordion6']; const top = el.
getBoundingClientRect(). top + window. pageYOffset - 80; // adjust offset window.
scrollTo({ top, behavior: 'smooth' }); Innovate UK Business Connect will hold an online briefing event on Monday 14 September at 11am: click here to register for a place . A recording and slides will be available afterwards. If you would like help to find a collaboration partner, contact Innovate UK Business Connect’s Biotechnology team .
Innovate UK's application and funding process If you need more information about how to apply, please read our funding support pages. For additional support, reach out to our team of innovation experts who are ready to help you navigate the application process and maximise your chances of success.
[url] => /how-we-help/innovation-funding-and-support/ Accessibility and Inclusion Innovate UK welcome and encourage applications from people of all backgrounds and are committed to making our application process accessible to everyone. This includes making reasonable adjustments, for people who have a disability or a long-term condition and face barriers applying to us. 14/09/2026 | 11.
00 - 12. 00 Engineering Biology Collaborative R&D: Round 3 briefing event If you have any questions about the scope requirements of this competition, email support@iuk. ukri.
org Our phone lines are open from 9am to 5pm, Monday to Friday (excluding bank holidays). This opportunity is part of Engineering Biology. Engineering Biology (EngBio) provides us with the opportunity to step away from traditional methods and provide innovative solutions for challenges brought by climate change and the associated impact areas, like food availability and the need for sustainable feedstocks.
Connect with Innovate UK Business Connect I agree to receive marketing communications, including newsletters, from Innovate UK Business Connect.
According to the current listing, eligibility includes: Open to collaborations. The lead organisation must be a UK registered business of any size. The consortium must include at least one UK registered micro, small or medium-sized enterprise (SME) claiming grant funding. Confirm the full requirements in the official notice before applying.
Applications for Engineering Biology Collaborative R&D: Round 3 are due December 2, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Engineering Biology Collaborative R&D: Round 3 is funded by Innovate UK (part of UKRI's Engineering Biology Programme). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The RUS Powering Affordable Reliable Technology (PART) Energy Program takes Letters of Interest until October 9, 2026. Up to 40% of each loan can be forgiven, awards run $1M to $100M, and USDA describes eligible generation as hydro, geothermal, and biomass — even though Section 317 of the RE Act names solar and wind.
Read articleThe Rural Utilities Service is putting $410 million of Section 22001 budget authority back in the market through the Powering Affordable Reliable Technology program. Letters of Interest open September 8 and close October 9, 2026 — both at 11:59 a.m., not p.m. — and RUS evaluates them on a rolling basis in the order received.
Read articleOMB's proposed rewrite of the Uniform Guidance would let political appointees pre-screen every discretionary grant, terminate active awards 'in the interest of the agency' with a brief note, and bar whole categories of costs. It drew nearly 500,000 comments and takes effect October 1, 2026. Here is what actually changes at the section level, who is exposed, and how to prepare now.
Read article